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TREATMENT OF
VERTEBRAL HEMAN-
L. Miszczyk1, K. Ficek1, K. Trela1 ,J. Spindel2
Aim - The aim of this study was to assess
efficacy of radiotherapy as a method of vertebrai
hemangiomas treatment.
Material and method - The material contains
14 cases of irradiated painful vertebrai
hemangiomas. Ali patients were treated using
conventional fractionation scheme (df = 2 Gy) up
to 20, 24 or 30 Gy. The lesion reossification and
degree of pain relief and correlations between it
and different biological and technical factors
were evaluated one and six months after
treatment completion.
Results - One month after treatment complete
pain relief was in 36% of cases (mean degree ot
of patients with multiple bone metastases.
Material and methods: From January 2000 to
October 2000 in our center were treated 41
patients; 17 - prostate cancer and 24 - breast
cancer patients. Ali patients had applied only
one dose of 150 MBq of 89 Sr. Before and
follow-up each patient has been evaluated;
performance status according to the Karnofsky
Scale and paro intensity according the VAS
scale. We did not observe any clinical important
haematological side effects. The ionisation
dosemetric monitoring of the sources and the
radioactive refuse were recorded. The
radioactive refuse was storage in special
container when the activity decreased to the
background.
Results: We noted relief of paro as follow:
- "complete" 18 of 41 patients (8-prostate
cancer, 10 - breast cancer),
- "partial" 12 of 41 patients (3- prostate
cancer, 9- breast cancer),
- "no effect" 11 of 41 patients (6-prostate
cancer, 5- breast cancer).
Conclusions: We suggest that therapy of
painful multiple bone metastases with
application of 89 Sr is effective nd safe.
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Aim of this study was to assessment of 89 Sr
therapy as pain treatment modality in the group
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Introduction: Between November 2000 and
January 2001 screening for prostate cancer has
been conducted in Greatpoland Cancer Centre.
Among men in Poland prostate cancer is one of
the most common cancers and cause of deaths.
The incidence of clinically diagnosed prostate
cancer rises more rapidly with age than does
any other malignancy.
Materiał and methods: The screening
involved 1657 male participants. Our research
was design with participants eligibility restricted
to men 50 to 70 years old who were not already
being evaluated for the disease.
Screening for prostate cancer was based on
prostate specific antigen and digital rectal
examination.
Results: Among patients with elevated PSA
level, analysis at PSA ratio was performed (52
patients).
Ali patients with abnormal PSA level and
digital examination had (TRUS). Biopsy was
performed for 6 patients. Three of them were
proven for cancer. During our research we
looked for genetic aspect of prostate cancer.
Conclusions: Screening for prostate cancer
was met with big enthusiasm among men and
hopefully very similar screening would be
introduced for larger group of patients.
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